Narcolepsy therapeutics refers to the medications and treatments used to manage a chronic sleep disorder marked by daytime sleepiness, sudden episodes of sleep, and, in some cases, cataplexy. Polaris Market Research values the narcolepsy therapeutics market at USD 3,819.10 million in 2024 and projects USD 7,852.93 million by 2034, a CAGR of 7.5% from 2025 to 2034. Awareness Is Lifting...